India’s high use of antigen tests risks underestimating Covid-19 spread, says diagnostician | Latest News India - Hindustan Times
close_game
close_game

India’s high use of antigen tests risks underestimating Covid-19 spread, says diagnostician

New Delhi | ByReuters | Posted by Ayshee Bhaduri
Oct 28, 2020 06:09 PM IST

India’s federal health ministry has not provided a breakdown of the test methods deployed, but state and federal officials have repeatedly defended the use of antigen tests to quickly identify infections in the country of 1.3 billion people

Fast but less accurate “rapid antigen tests” now account for 60% of all coronavirus tests in India, the head of a top diagnostic firm estimated on Wednesday, warning that such a high use could misrepresent the actual spread of the infection.

Whereas antigen tests typically detect the virus around 80% to 90% of the time, lab based tests detect the virus more than 95% of the time, say regulators and health experts in countries like the United States(HT photo)
Whereas antigen tests typically detect the virus around 80% to 90% of the time, lab based tests detect the virus more than 95% of the time, say regulators and health experts in countries like the United States(HT photo)

Antigen devices return results in about 15 minutes compared with several hours for the reverse transcription polymerase chain reaction (RT-PCR) method, a laboratory based process which the US Centres for Disease Control and Prevention(CDC) calls the “gold standard“ for Covid-19 detection.

Hindustan Times - your fastest source for breaking news! Read now.

Whereas antigen tests typically detect the virus around 80% to 90% of the time, lab based tests detect the virus more than 95% of the time, say regulators and health experts in countries like the United States.

As a consequence of the reduced accuracy, India’s high use of antigen tests compared with a global use of around 10%, risked underestimating the spread of coronavirus, according to the founder of Mumbai based Thyrocare Technologies Ltd , one of India’s top-three diagnostic chains.

“It’s a wrong scale used to assess” the extent of the spread of the virus, Arokiaswamy Velumani told Reuters in a phone interview.

Though the total number of coronavirus cases reached close to 8 million on Wednesday, India’s official tally shows daily new cases have dropped sharply since a mid-September peak.

Velumani said Thyrocare’s centres are now receiving only about 2,500 samples a day for RT-PCR tests, down from a high of about 7,000 in September.

The health ministry and the Indian Council of Medical Research(ICMR) did not immediately respond to emails from Reuters seeking comment on Velumani’s comments.

RT-PCR dominates in the United States but authorities there are planning to increase the use of antigen tests to screen people.

India’s federal health ministry has not provided a breakdown of the test methods deployed, but state and federal officials have repeatedly defended the use of antigen tests to quickly identify infections in the country of 1.3 billion people.

It has also helped India quickly ramp up its testing capacity to 1.5 million samples a day.

“There was a stigma that India was not doing enough tests,” Velumani said, noting at least that criticism was being addressed.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On